First Eagle Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

First Eagle Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50,000	Closed	-$100K	–	306
2017 Q4	$100K	Hold	50,000	–	–	﹤0.01%	282
2017 Q3	$162K	Buy	50,000 +30,000	+150%	+$92.6K	﹤0.01%	289
2017 Q2	$64K	Hold	20,000	–	–	﹤0.01%	284
2017 Q1	$57K	Hold	20,000	–	–	﹤0.01%	280
2016 Q4	$47K	Hold	20,000	–	–	﹤0.01%	283
2016 Q3	$34K	Hold	20,000	–	–	﹤0.01%	305
2016 Q2	$21K	Hold	20,000	–	–	﹤0.01%	325
2016 Q1	$17K	Hold	20,000	–	–	﹤0.01%	312
2015 Q4	$24K	Hold	20,000	–	–	﹤0.01%	301
2015 Q3	$34K	Hold	20,000	–	–	﹤0.01%	285
2015 Q2	$42K	Hold	20,000	–	–	﹤0.01%	276
2015 Q1	$54K	Hold	20,000	–	–	﹤0.01%	290
2014 Q4	$51K	Hold	20,000	–	–	﹤0.01%	295
2014 Q3	$37K	Hold	20,000	–	–	﹤0.01%	299
2014 Q2	$53K	Hold	20,000	–	–	﹤0.01%	285
2014 Q1	$70K	Hold	20,000	–	–	﹤0.01%	339
2013 Q4	$90K	Hold	20,000	–	–	﹤0.01%	320
2013 Q3	$81K	Hold	20,000	–	–	﹤0.01%	306
2013 Q2	$83K	Buy	+20,000	New	+$77.3K	﹤0.01%	310

Other funds holding ATRS

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management's ATRS Position: Q1 2018 in Review

First Eagle Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2018, closing a stake of 50,000 shares — an estimated $100K sold.

First Eagle Investment Management first reported a position in ATRS in Q2 2013 and held it in 19 quarters. The position peaked at $162K in Q3 2017. 102 funds tracked by Wall St. Rank hold ATRS as of Q1 2018.

First Eagle Investment Management reported no remaining Antares Pharma, Inc. position as of Q1 2018 after selling out during the quarter.
First Eagle Investment Management sold 50,000 Antares Pharma, Inc. shares in Q1 2018, an estimated $100K.
First Eagle Investment Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 19 quarters.
First Eagle Investment Management's Antares Pharma, Inc. position peaked at $162K in Q3 2017.
102 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2018.

Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.